Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christer Groeben

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Urologie (Heidelberg, Germany)|August 4, 2022
[Acceptance and status of digitalization in clinics and practices : Current assessment in German urology]Angelika Borkowetz, Marianne Leitsmann, Martin Baunacke, et al.
World Journal of Urology|January 12, 2023
Hospital rating websites play a minor role for uro-oncologic patients when choosing a hospital for major surgery: results of the German multicenter NAVIGATOR-studyChrister Groeben, Katharina Boehm, Rainer Koch, et al.
Cell Reports|February 23, 2022
Cellular plasticity upon proton irradiation determines tumor cell radiosensitivityIñaki Schniewind, Wahyu Wijaya Hadiwikarta, Julia Grajek, et al.
Urologie (Heidelberg, Germany)|January 20, 2025
[How will hybrid-DRGs (diagnosis related groups) change German urology? : A survey and potential analysis]Philipp Reimold, Christer Groeben, Angelika Borkowetz, et al.
Journal of Medical Internet Research|April 7, 2025
Urologists' Estimation of Online Support Group Utilization Behavior of Their Patients With Newly Diagnosed Nonmetastatic Prostate Cancer in Germany: Predefined Secondary Analysis of a Randomized Controlled TrialPhilipp Karschuck, Christer Groeben, Rainer Koch, et al.
European Urology Focus|September 9, 2025
Effects of a Patient Decision Aid for Nonmetastatic Prostate Cancer Established in Routine Care: The Randomized Controlled EvEnt-PCA TrialJohannes Huber, Philipp Karschuck, Rainer Koch, et al.
Theranostics|August 2, 2021
GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagyAnna Mukha, Uğur Kahya, Annett Linge, et al.
Cancer Genetics|April 8, 2026
Optimized precision oncology through implementation of a comprehensive molecular analysis pipeline - relevance for additional therapeutic optionsNuwar Harb, Marcel Romey, Albert Grass, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Urologie (Heidelberg, Germany)|August 4, 2022
[Acceptance and status of digitalization in clinics and practices : Current assessment in German urology]Angelika Borkowetz, Marianne Leitsmann, Martin Baunacke, et al.
World Journal of Urology|January 12, 2023
Hospital rating websites play a minor role for uro-oncologic patients when choosing a hospital for major surgery: results of the German multicenter NAVIGATOR-studyChrister Groeben, Katharina Boehm, Rainer Koch, et al.
Cell Reports|February 23, 2022
Cellular plasticity upon proton irradiation determines tumor cell radiosensitivityIñaki Schniewind, Wahyu Wijaya Hadiwikarta, Julia Grajek, et al.
Urologie (Heidelberg, Germany)|January 20, 2025
[How will hybrid-DRGs (diagnosis related groups) change German urology? : A survey and potential analysis]Philipp Reimold, Christer Groeben, Angelika Borkowetz, et al.
Journal of Medical Internet Research|April 7, 2025
Urologists' Estimation of Online Support Group Utilization Behavior of Their Patients With Newly Diagnosed Nonmetastatic Prostate Cancer in Germany: Predefined Secondary Analysis of a Randomized Controlled TrialPhilipp Karschuck, Christer Groeben, Rainer Koch, et al.
European Urology Focus|September 9, 2025
Effects of a Patient Decision Aid for Nonmetastatic Prostate Cancer Established in Routine Care: The Randomized Controlled EvEnt-PCA TrialJohannes Huber, Philipp Karschuck, Rainer Koch, et al.
Theranostics|August 2, 2021
GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagyAnna Mukha, Uğur Kahya, Annett Linge, et al.
Cancer Genetics|April 8, 2026
Optimized precision oncology through implementation of a comprehensive molecular analysis pipeline - relevance for additional therapeutic optionsNuwar Harb, Marcel Romey, Albert Grass, et al.
Pageof 7